Pharmacy

Richmond Pharmacology has integrated MHRA-licensed pharmacies located within each of their trial centres.

The pharmacies have been designed, commissioned and are operated in compliance with MHRA best practice and GMP guidelines.

The pharmacies are temperature controlled throughout and are connected to a sophisticated ‘auto-dialler’ alarm system. Richmond Pharmacology has the ability to store IMPs in a wide range of conditions to meet a sponsor’s requirements. Ambient and storage temperatures are continuously monitored and all temperature data is exported and signed off electronically. Stored temperature logs are available upon request.

Richmond Pharmacology pharmacies are staffed by 3 pharmacists with extensive experience of IMP preparation and dispensing for clinical trials. Pharmacy supervision is under the control of 3 licensed QPs

Our full-service offering includes a broad array of services. Our experienced staff are able to accommodate additional requirements at the request of our sponsors.

Our offering includes:

  • Licensed for storage and dispensing of controlled drugs
  • Preparation of study specific Pharmacy Manuals
  • Generation of Randomisation Schedules and Code Break Envelopes
  • IMP label production
  • Assembly and repackaging
  • Manufacture of solid and liquid dosage forms
  • Batch QP Certification
  • Importation of IMPs from non-EU countries
  • At study close-out, IMP reconciliation and destruction or retention

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

What 20 years of clinical research has taught us about our industry and the future of drug development

June 9, 2021
As Richmond Pharmacology approaches its 20th anniversary our co-founder and CEO reflects on the developments, regulatory changes, and innovations within the life science industry in an article in the PharmaTimes.
Read more

Do we still need challenge trials with COVID-19?

April 21, 2021
Nir Eyal and colleagues suggested that the initiation of COVID-19 challenge trials in response to the UK governments’ call in 2020 remained relevant and important despite the development of approved vaccines and the introduction of an aggressive, UK-wide vaccination policy.
Read more

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.
Read more